Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192

1.

Management of Adolescents with Hidradenitis Suppurativa.

Collier E, Shi VY, Hsiao JL.

J Dermatolog Treat. 2020 Jan 14:1-15. doi: 10.1080/09546634.2020.1716933. [Epub ahead of print]

PMID:
31933397
2.

Clinical Pearls for Managing Hidradenitis Suppurativa Patients of Low Socioeconomic Status.

McKenzie SA, Lev-Tov HA, Shi VY, Hsiao JL.

Dermatology. 2020 Jan 10:1-6. doi: 10.1159/000505149. [Epub ahead of print] No abstract available.

PMID:
31927547
3.

Diet and Chronic Urticaria: Dietary Modification as a Treatment Strategy.

Jaros J, Shi VY, Katta R.

Dermatol Pract Concept. 2019 Dec 31;10(1):e2020004. doi: 10.5826/dpc.1001a04. eCollection 2020.

4.

Race and Ethnicity Gaps in Global Hidradenitis Suppurativa Clinical Trials.

Price KN, Hsiao JL, Shi VY.

Dermatology. 2019 Dec 20:1-6. doi: 10.1159/000504911. [Epub ahead of print] Review.

5.

The impact of airborne pollution on atopic dermatitis: a literature review.

Hendricks AJ, Eichenfield LF, Shi VY.

Br J Dermatol. 2019 Dec 3. doi: 10.1111/bjd.18781. [Epub ahead of print] Review.

PMID:
31794065
6.

Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.

Solomon SD, Vaduganathan M, Claggett BL, Packer M, Zile M, Swedberg K, Rouleau J, Pfeffer MA, Desai A, Lund LH, Koeber L, Anand I, Sweitzer NK, Linssen G, Merkely B, Arango JL, Vinereanu D, Chen CH, Senni M, Sibulo A, Boytsov S, Shi V, Rizkala A, Lefkowitz M, McMurray JJV.

Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044586. [Epub ahead of print]

PMID:
31736342
7.

Effects of Sacubitril-Valsartan, versus Valsartan, in Women Compared to Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF.

McMurray JJV, Jackson AM, Lam CSP, Redfield MM, Anand IS, Ge J, Lefkowitz MP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Rizkala AR, Sabarwal SV, Shah AM, Shah SJ, Shi VC, van Veldhuisen DJ, Zannad F, Zile MR, Cikes M, Goncalvesova E, Katova T, Kosztin A, Lelonek M, Sweitzer NK, Vardeny O, Claggett B, Jhund PS, Solomon SD.

Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044491. [Epub ahead of print]

PMID:
31736337
8.

Provider landscape for hidradenitis suppurativa patients.

Berman HS, Shi VY, Hsiao JL.

Int J Dermatol. 2019 Nov 18. doi: 10.1111/ijd.14719. [Epub ahead of print] No abstract available.

PMID:
31736054
9.

Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared with Valsartan in HFpEF.

Vaduganathan M, Claggett BL, Desai AS, Anker SD, Perrone SV, Janssens S, Milicic D, Arango JL, Packer M, Shi VC, Lefkowitz MP, McMurray JJV, Solomon SD.

J Am Coll Cardiol. 2019 Nov 6. pii: S0735-1097(19)38299-3. doi: 10.1016/j.jacc.2019.11.003. [Epub ahead of print]

PMID:
31726194
10.

Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.

Hendricks AJ, Yosipovitch G, Shi VY.

J Dermatolog Treat. 2019 Nov 12:1-10. doi: 10.1080/09546634.2019.1689227. [Epub ahead of print]

PMID:
31693426
11.

Supply Chain Partner Communication in a Managed Programme in the UK Water Industry: A Case Study with Social Network Analysis.

Li Q, Wang S, Shaw N, Shi V.

Int J Environ Res Public Health. 2019 Oct 30;16(21). pii: E4211. doi: 10.3390/ijerph16214211.

12.

Pharmacy costs of systemic and topical medications for atopic dermatitis.

Mata E, Loh TY, Ludwig C, Price KN, Fernandez JM, Krase JM, Shi VY.

J Dermatolog Treat. 2019 Nov 12:1-3. doi: 10.1080/09546634.2019.1687811. [Epub ahead of print] No abstract available.

PMID:
31670992
13.

A Comparison of International Management Guidelines for Hidradenitis Suppurativa.

Hendricks AJ, Hsiao JL, Lowes MA, Shi VY.

Dermatology. 2019 Oct 23:1-16. doi: 10.1159/000503605. [Epub ahead of print] Review.

14.

A practical guide for transitioning from classical immunosuppressants to dupilumab in atopic dermatitis.

Ludwig CM, Krase JM, Price KN, Lio PA, Shi VY.

J Dermatolog Treat. 2019 Nov 25:1-4. doi: 10.1080/09546634.2019.1682498. [Epub ahead of print] No abstract available.

PMID:
31619094
15.

Glycan-dependent HIV-specific neutralizing antibodies bind to cells of uninfected individuals.

Blazkova J, Refsland EW, Clarridge KE, Shi V, Justement JS, Huiting ED, Gittens KR, Chen X, Schmidt SD, Liu C, Doria-Rose N, Mascola JR, Heredia A, Moir S, Chun TW.

J Clin Invest. 2019 Nov 1;129(11):4832-4837. doi: 10.1172/JCI125955.

16.

Bioactive: A new era of bioactive ingredients in topical formulations for inflammatory dermatoses.

Yang EJ, Hendricks AJ, Beck KM, Shi VY.

Dermatol Ther. 2019 Nov;32(6):e13101. doi: 10.1111/dth.13101. Epub 2019 Oct 11.

PMID:
31583790
17.

Isotretinoin in the treatment of hidradenitis suppurativa: a retrospective study.

Patel N, McKenzie SA, Harview CL, Truong AK, Shi VY, Chen L, Grogan TR, Bennett RG, Hsiao JL.

J Dermatolog Treat. 2019 Sep 26:1-3. doi: 10.1080/09546634.2019.1670779. [Epub ahead of print]

PMID:
31535587
18.

Clinical Pearls on Sleep Management in Atopic Dermatitis.

Hendricks AJ, Manivannan M, Shi VY.

Dermatitis. 2019 Sep/Oct;30(5):287-293. doi: 10.1097/DER.0000000000000523.

PMID:
31524756
19.

Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF.

Selvaraj S, Claggett B, Pozzi A, McMurray JJV, Jhund PS, Packer M, Desai AS, Lewis EF, Vaduganathan M, Lefkowitz MP, Rouleau JL, Shi VC, Zile MR, Swedberg K, Solomon SD.

Circulation. 2019 Oct 22;140(17):1369-1379. doi: 10.1161/CIRCULATIONAHA.119.039920. Epub 2019 Sep 12.

PMID:
31510768
20.

An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals.

Sneller MC, Clarridge KE, Seamon C, Shi V, Zorawski MD, Justement JS, Blazkova J, Huiting ED, Proschan MA, Mora JR, Shetzline M, Moir S, Lane HC, Chun TW, Fauci AS.

Sci Transl Med. 2019 Sep 11;11(509). pii: eaax3447. doi: 10.1126/scitranslmed.aax3447. Epub 2019 Sep 5.

PMID:
31488581
21.

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Claggett B, Jhund PS, Boytsov SA, Comin-Colet J, Cleland J, Düngen HD, Goncalvesova E, Katova T, Kerr Saraiva JF, Lelonek M, Merkely B, Senni M, Shah SJ, Zhou J, Rizkala AR, Gong J, Shi VC, Lefkowitz MP; PARAGON-HF Investigators and Committees.

N Engl J Med. 2019 Oct 24;381(17):1609-1620. doi: 10.1056/NEJMoa1908655. Epub 2019 Sep 1.

PMID:
31475794
22.

Undergarment and Fabric Selection in the Management of Hidradenitis Suppurativa.

Loh TY, Hendricks AJ, Hsiao JL, Shi VY.

Dermatology. 2019 Aug 29:1-6. doi: 10.1159/000501611. [Epub ahead of print] Review.

23.

Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis.

Carnicle JM, Hendricks AJ, Shi VY.

Dermatitis. 2019 Aug 21. doi: 10.1097/DER.0000000000000512. [Epub ahead of print] No abstract available.

PMID:
31441782
24.

Skin bacterial transplant in atopic dermatitis: Knowns, unknowns and emerging trends.

Hendricks AJ, Mills BW, Shi VY.

J Dermatol Sci. 2019 Aug;95(2):56-61. doi: 10.1016/j.jdermsci.2019.07.001. Epub 2019 Jul 5. Review.

PMID:
31395434
25.

Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease.

Berman HS, Villa NM, Shi VY, Hsiao JL.

J Dermatolog Treat. 2019 Aug 25:1-3. doi: 10.1080/09546634.2019.1654067. [Epub ahead of print]

PMID:
31389737
26.

Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.

Chandra A, Vaduganathan M, Lewis EF, Claggett BL, Rizkala AR, Wang W, Lefkowitz MP, Shi VC, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, McMurray JJV, Solomon SD; PARAGON-HF Investigators.

JACC Heart Fail. 2019 Oct;7(10):862-874. doi: 10.1016/j.jchf.2019.05.015. Epub 2019 Jul 10.

PMID:
31302043
27.

Topical probiotics: the unknowns behind their rising popularity.

Lee GR, Maarouf M, Hendricks AJ, Lee DE, Shi VY.

Dermatol Online J. 2019 May 15;25(5). pii: 13030/qt2v83r5wk. Review.

28.

In Vivo Reflectance Confocal Microscopy: Emerging Role in Noninvasive Diagnosis and Monitoring of Eczematous Dermatoses.

Maarouf M, Costello CM, Gonzalez S, Angulo I, Curiel-Lewandrowski CN, Shi VY.

Actas Dermosifiliogr. 2019 Oct;110(8):626-636. doi: 10.1016/j.ad.2018.08.008. Epub 2019 Jun 13. Review. English, Spanish.

PMID:
31202471
29.

Skin Cancer Epidemiology and Sun Protection Behaviors Among Native Americans

Maarouf M, Zullo SW, DeCapite T, Shi VY.

J Drugs Dermatol. 2019 May 1;18(5):420-423.

PMID:
31141849
30.

Rosacea associated with dupilumab therapy.

Heibel HD, Hendricks AJ, Foshee JP, Shi VY.

J Dermatolog Treat. 2019 Jun 9:1-3. doi: 10.1080/09546634.2019.1624683. [Epub ahead of print]

PMID:
31132923
31.

Non-pharmacologic approaches for hidradenitis suppurativa - a systematic review.

Hendricks AJ, Hirt PA, Sekhon S, Vaughn AR, Lev-Tov HA, Hsiao JL, Shi VY.

J Dermatolog Treat. 2019 Jun 4:1-8. doi: 10.1080/09546634.2019.1621981. [Epub ahead of print]

PMID:
31106609
32.

Bathing Additives for Atopic Dermatitis - A Systematic Review.

Maarouf M, Hendricks AJ, Shi VY.

Dermatitis. 2019 May/Jun;30(3):191-197. doi: 10.1097/DER.0000000000000459.

PMID:
31094942
33.

Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF.

Balmforth C, Simpson J, Shen L, Jhund PS, Lefkowitz M, Rizkala AR, Rouleau JL, Shi V, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV.

JACC Heart Fail. 2019 Jun;7(6):457-465. doi: 10.1016/j.jchf.2019.02.015. Epub 2019 May 8.

34.

Dupilumab and Alopecia: Causative or Therapeutic?

Hendricks AJ, Lio PA, Shi VY.

Dermatology. 2019;235(4):306-307. doi: 10.1159/000499080. Epub 2019 Apr 18. No abstract available.

PMID:
30999308
35.

Learning About Dupilumab-Associated Conjunctivitis.

Hendricks AJ, Shi VY.

JAMA Dermatol. 2019 Jun 1;155(6):754. doi: 10.1001/jamadermatol.2018.5951. No abstract available.

PMID:
30994889
36.

Animated video consultation for reducing pre-operative anxiety in dermatologic surgery.

Platto JF, Maarouf M, Hendricks A, Kurtzman DJ, Shi VY.

Dermatol Online J. 2019 Mar 15;25(3). pii: 13030/qt5f51t2xf.

37.

5-fluorouracil-induced erythema and transepidermal water loss associated with complete actinic keratosis resolution.

Maarouf M, Kromenacker BW, Brucks ES, Hendricks AJ, Shi VY.

Dermatol Ther. 2019 May;32(3):e12890. doi: 10.1111/dth.12890. Epub 2019 Apr 17. No abstract available.

PMID:
30942937
38.

Management Recommendations for Dupilumab Partial and Non-durable Responders in Atopic Dermatitis.

Hendricks AJ, Lio PA, Shi VY.

Am J Clin Dermatol. 2019 Aug;20(4):565-569. doi: 10.1007/s40257-019-00436-8.

PMID:
30919315
39.

Micronutrients in Atopic Dermatitis: A Systematic Review.

Vaughn AR, Foolad N, Maarouf M, Tran KA, Shi VY.

J Altern Complement Med. 2019 Jun;25(6):567-577. doi: 10.1089/acm.2018.0363. Epub 2019 Mar 26.

PMID:
30912673
40.

Augmented Intelligence in Dermatology: Fantasy or Future?

Kromenacker B, Maarouf M, Shi VY.

Dermatology. 2019;235(3):250-252. doi: 10.1159/000497275. Epub 2019 Mar 19. No abstract available.

PMID:
30889594
41.

A New Era For Tattoos, with New Potential Complications.

Maarouf M, Saberian C, Segal RJ, Shi VY.

J Clin Aesthet Dermatol. 2019 Feb;12(2):37-38. Epub 2019 Feb 1.

42.

B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.

Myhre PL, Vaduganathan M, Claggett B, Packer M, Desai AS, Rouleau JL, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD.

J Am Coll Cardiol. 2019 Mar 26;73(11):1264-1272. doi: 10.1016/j.jacc.2019.01.018. Epub 2019 Mar 4.

PMID:
30846338
43.

Impact of Treatment Interruption on HIV Reservoirs and Lymphocyte Subsets in Individuals Who Initiated Antiretroviral Therapy During the Early Phase of Infection.

Huiting ED, Gittens K, Justement JS, Shi V, Blazkova J, Benko E, Kovacs C, Wender PA, Moir S, Sneller MC, Fauci AS, Chun TW.

J Infect Dis. 2019 Jun 19;220(2):270-274. doi: 10.1093/infdis/jiz100.

PMID:
30840763
44.

Bathing Additives for Atopic Dermatitis-A Systematic Review.

Maarouf M, Hendricks AJ, Shi VY.

Dermatitis. 2019 Mar 4. doi: 10.1097/DER.0000000000000459. [Epub ahead of print]

PMID:
30839318
45.

Reducing unpleasant side effects of topical 5-Fluorouracil treatment for actinic keratosis: a randomized controlled trial.

Maarouf M, Kromenacker BW, Brucks ES, Hendricks A, Shi VY.

J Dermatolog Treat. 2020 Mar;31(2):175-179. doi: 10.1080/09546634.2019.1589638. Epub 2019 Mar 21.

PMID:
30821548
46.

Anticipating the era of dermatology disease trackers.

Hendricks AJ, Shi VY.

Br J Dermatol. 2019 Jun;180(6):1523-1524. doi: 10.1111/bjd.17635. No abstract available.

PMID:
30786003
47.

Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF.

Zile MR, O'Meara E, Claggett B, Prescott MF, Solomon SD, Swedberg K, Packer M, McMurray JJV, Shi V, Lefkowitz M, Rouleau J.

J Am Coll Cardiol. 2019 Feb 26;73(7):795-806. doi: 10.1016/j.jacc.2018.11.042.

PMID:
30784673
48.

Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.

Vardeny O, Claggett B, Kachadourian J, Desai AS, Packer M, Rouleau J, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD.

Eur J Heart Fail. 2019 Mar;21(3):337-341. doi: 10.1002/ejhf.1402. Epub 2019 Feb 11.

49.

Current and emerging therapies for hand eczema.

Lee GR, Maarouf M, Hendricks AK, Lee DE, Shi VY.

Dermatol Ther. 2019 May;32(3):e12840. doi: 10.1111/dth.12840. Epub 2019 Feb 18. Review.

PMID:
30693618
50.

The impact of stress on epidermal barrier function: an evidence-based review.

Maarouf M, Maarouf CL, Yosipovitch G, Shi VY.

Br J Dermatol. 2019 Dec;181(6):1129-1137. doi: 10.1111/bjd.17605. Epub 2019 Mar 18. Review.

PMID:
30614527

Supplemental Content

Support Center